Cargando…
Delayed Response to U-500 Regular Insulin
Autor principal: | Davidson, Mayer B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775001/ https://www.ncbi.nlm.nih.gov/pubmed/29382984 http://dx.doi.org/10.2337/cd16-0058 |
Ejemplares similares
-
Development and Implementation of a U-500 Regular Insulin Program in a Federally Qualified Health Center
por: Shaw, Kathy F., et al.
Publicado: (2017) -
Erratum: Delayed Response to U-500 Regular Insulin. Clinical Diabetes 2018;36: 77–79 (DOI: 10.2337/cd16-0058)
por: Davidson, Mayer B.
Publicado: (2018) -
U-500 Regular Insulin: Clinical experience and pharmacokinetics in obese, severely insulin-resistant type 2 diabetic patients
por: Davidson, Mayer B., et al.
Publicado: (2010) -
Human Regular 500 units/mL Insulin Therapy: A Review of Clinical Evidence and New Delivery Options
por: Sze, David, et al.
Publicado: (2018) -
MON-152 Less Is More: Human Regular U-500 Insulin
por: Lugo Lopez, Zahira, et al.
Publicado: (2019)